Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
European Urology Oncology
|
July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update
Georgios Gakis, Harman M Bruins, Richard Cathomas, et al.
Clinical Genitourinary Cancer
|
July 25, 2016
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
Dimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, et al.
European Urology Open Science
|
March 6, 2023
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
Stefanie Fischer, Christian Rothermundt, Odile Stalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
The Lancet. Oncology
|
October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
Swiss Medical Weekly
|
July 26, 2018
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Christian Rothermundt, Claudio Thurneysen, Richard Cathomas, et al.
European Urology
|
April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
European Urology Focus
|
June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer
Mithun Kailavasan, Alberto Martini, Max Bruins, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
European Urology Oncology
|
July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update
Georgios Gakis, Harman M Bruins, Richard Cathomas, et al.
Clinical Genitourinary Cancer
|
July 25, 2016
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program
Dimitrios Papazoglou, Luciano Wannesson, Dominik Berthold, et al.
European Urology Open Science
|
March 6, 2023
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
Stefanie Fischer, Christian Rothermundt, Odile Stalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
The Lancet. Oncology
|
October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
Swiss Medical Weekly
|
July 26, 2018
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Christian Rothermundt, Claudio Thurneysen, Richard Cathomas, et al.
European Urology
|
April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
European Urology Focus
|
June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer
Mithun Kailavasan, Alberto Martini, Max Bruins, et al.
Page
of 14